Skip to content

UFP Technologies UFPT Convertible Preferred Stock Issued Shares

Convertible Preferred Stock Issued Shares at other companies

Medline, Inc.
 logo
Medline, Inc. MDLN
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$154.2M+4.1%
Gross profit$44.4M+5.2%
Operating income$23.4M+1.0%
Net income$17.5M+1.8%
EPS (diluted)$2.24+1.4%

Balance sheet

See full
Cash & equivalents$20.0M+42.4%
Total debt$156.1M-21.4%
Total equity$438.9M+21.7%
Total assets$674.7M+5.0%

Cash flow

See full
Operating cash flow$3.2M-76.8%
CapEx$2.9M+3.1%
Free cash flow$22.5M+151%

Valuation

See full
Market cap$1.88B-3.6%

Profitability

See full
Gross margin28.4%-0.6pp
Operating margin15.2%-0.9pp
Net margin11.3%-0.3pp
FCF margin12.3%+2.0pp

Returns & leverage

See full
Return on equity17.2%-2.2pp
Debt / equity0.4×-0.2×
Current ratio2.9×+0.3×

Where this comes from

Reported directly by UFP Technologies in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.

The official record: UFP Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is UFP Technologies's convertible preferred stock issued shares?
UFP Technologies (UFPT) reported convertible preferred stock issued shares of 0 in Q1 2026.
What does convertible preferred stock issued shares mean?
Number of convertible preferred shares that have been issued, whether held by investors or in treasury.